AFLATOXIN-INDUCED HEPATIC FIBROSIS IN RHESUS MONKEYS. PATHOLOGICAL FEATURES.
D000348:Aflatoxins; D000469:Alkaline Phosphatase / Q000097:blood*; D000818:Animals; D000992:Antitoxins; D001219:Aspartate Aminotransferases; D001230:Aspergillus; D001652:Bile Ducts; D001653:Bile Ducts, Intrahepatic; D001663:Bilirubin; D002273:Carcinogens; D005234:Fatty Liver; D000882:Haplorhini; D008103:Liver Cirrhosis; D008253:Macaca mulatta; D010336:Pathology; D011168:Portal System; D012106:Research; D014116:Toxicology; D014118:Toxins, Biological
D000348:Aflatoxins; D000992:Antitoxins; D002273:Carcinogens; D014118:Toxins, Biological; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001663:Bilirubin
AFLATOXIN; ASPARTATE AMINOTRANSFERASE; ASPERGILLUS; BILE DUCTS, INTRAHEPATIC; BILIRUBIN; BLOOD ALKALINE PHOSPHATASE; CARCINOGENS; EXPERIMENTAL LAB STUDY; FATTY LIVER; LIVER CIRRHOSIS; MONKEYS; PATHOLOGY; PORTAL SYSTEM; TOXICOLOGIC REPORT; TOXINS AND ANTITOXINS